Thoracic Oncology

HomeMembersAssemblies and SectionsAssemblies ▶ Thoracic Oncology
Assembly on Thoracic Oncology

TOA

 

ATS / ALA Implementation Guide for Lung Cancer Screening


Welcome Message

Lynn T. Tanoue, MD
Assembly Chair
Lynn T. Tanoue, MD, MBA

Welcome to the Thoracic Oncology Assembly (TOA).  We are committed to improving the lives of all patients with thoracic malignancies.  Our members advance the field through scientific and clinical research that enhance our understanding of the biologic mechanisms that drive neoplasia, patient-centered clinical initiatives and clinical trials spanning care from early detection through treatment of advanced disease, education of patients and providers, and advocacy.   The Assembly structure promotes interdisciplinary communication, content programming, project development, membership engagement, and collaboration with industry and our sister pulmonary and oncology societies.

Before getting into the activities of the assembly, the TOA Leadership team sends a heartfelt greeting to all of our colleagues involved in the global response to COVID-19.  The disruption to our families, communities, and institutions has been extraordinary, but witnessing our collective heath care community’s remarkable response to the pandemic has been inspirational.  We hope that everyone is staying as safe as possible as we forge ahead to provide quality care while intently engaging in the basic, translational and clinical research that will inform our future strategies to control the pandemic.

Looking ahead to 2020-2021, the TOA Leadership team (see below) encourages our members to participate in the many activities of the assembly.  These include programming of scientific sessions at the annual International Conference, development of projects and documents that advance the science and clinical practice of lung cancer, development of web-based products and tools to educate providers and patients, and providing opportunities within ATS for groups with shared specific interests.  These latter include the Early Career Professionals Working Group, the Science and Innovation Center, the PhD and Basic & Translational Scientists Working Group, and the newly formed Interventional Pulmonary Advisory Committee. 

Our assembly membership draws from the diverse disciplines involved in lung cancer research and clinical care, including pulmonologists, thoracic surgeons, thoracic radiologists, epidemiologists and clinical and basic science researchers.  We are a young and rapidly growing assembly, with membership steadily increasing over the 6 years since TOA was established. ATS prominence in the field of thoracic oncology has increased through TOA efforts, including an increasing presence at the International Conference, lung cancer-focused document production, publications in ATS journals, and interactions with national and international organizations focused on cancer.

We strongly encourage all TOA members to get involved in assembly activities.  Please feel free to contact any of the Leadership team or indicate your interest through the GET INVOLVED! link on our website. 

Warmest regards,

Lynn T. Tanoue, MD, MBA  


Thoracic Oncology Leadership

Position

Person

Term

Assembly Chair Lynn Tanoue, MD, MBA 2019-2021
Assembly Chair-elect Patrick Nana-Sinkam, MD 2020-2021
Planning Committee Chair Pierre Massion, MD 2020-2021

Planning Committee Co-chair

Hasmeena Kathuria, MD

2020-2021

Program Committee Chair

Robert Keith, MD

2020-2021

Program Committee Chair-Elect

Jed Gorden, MD

2020-2021

Nominating Committee Chair

Michael Gould, MD

2020-2021

Early Career Professionals Working Group Chair

Lori Sakoda, PhD

2020-2022

Web Director    

Arjan Flora, MD

2020-2022

Science and Innovation Center (SIC) Representative

Seyed Moghaddam, MD

2020-2021

PhD and Basic & Translational Scientists Working Group

Rajkumar Savai, PhD

2020-2021

Interventional Pulmonary Advisory Group

Lonny Yarmus, DO, MBA

2020-2021